ALZ exerts its immunomodulatory action through binding to the CD52 antigen and the subsequent lysis and depletion of mature circulating CD52 + immune cells; thus, a transient but profound immunosuppression status with relatively brief B cell lymphopenia and prolonged T-cell lymphopenia, overlaps and is followed by an immune reconstitution phase. The gene discussed is CD52; the disease is lymphopenia.